Imran J. Rehmani
Papers
1
Total Citations
58
H-Index
1
About
Imran J. Rehmani is a researcher whose work sits at the intersection of analytical chemistry, high-throughput automation, and clinical toxicology. His primary contributions center on developing robust, scalable methods for quantifying biomarkers of tobacco exposure—specifically nicotine and its major metabolites, along with the minor alkaloids anatabine and anabasine—in human urine. His most cited work, a 2014 paper describing a high-throughput robotic sample preparation system coupled with HPLC-MS/MS, has garnered 58 citations, reflecting its practical impact on large-scale epidemiological and smoking-cessation studies. By integrating automated liquid handling with sensitive mass spectrometric detection, Rehmani’s method dramatically increased sample throughput while maintaining analytical precision, enabling researchers to process hundreds of samples per day. This innovation has been instrumental in advancing our understanding of nicotine metabolism and exposure patterns across diverse populations. His work exemplifies how engineering-driven analytical solutions can bridge the gap between laboratory precision and real-world public health research, making him a key figure in the field of bioanalytical method development.
Research Focus
Key Achievements
Top Papers
- 1